MLchartDataset catalogue

MLN1202

Term · Oncology and biomedicine · MLC-T-ONC-005435

A substance being studied as a treatment for atherosclerosis (a build-up of fat in the arteries). It is also being studied in the treatment of cancers that spread to the bone. MLN1202 binds to a protein called CCR2, which is found on the surface of certain bone cells, white blood cells, and cancer cells. MLN1202 blocks the action of a substance that is involved in keeping healthy bone mass. It may help keep the cancer cells from spreading to and growing in the bone. It is a type of monoclonal antibody. Also called anti-CCR2 monoclonal antibody MLN1202.

Table 1. Record
IdentifierMLC-T-ONC-005435
FieldOncology and biomedicine
Expansionsanti-CCR2 monoclonal antibody MLN1202
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-005435",
  "term": "MLN1202",
  "field": "Oncology and biomedicine",
  "definition": "A substance being studied as a treatment for atherosclerosis (a build-up of fat in the arteries). It is also being studied in the treatment of cancers that spread to the bone. MLN1202 binds to a protein called CCR2, which is found on the surface of certain bone cells, white blood cells, and cancer cells. MLN1202 blocks the action of a substance that is involved in keeping healthy bone mass. It may help keep the cancer cells from spreading to and growing in the bone. It is a type of monoclonal antibody. Also called anti-CCR2 monoclonal antibody MLN1202.",
  "expansions": [
    "anti-CCR2 monoclonal antibody MLN1202"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/mln1202/"
}

Record 11,142 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.